Abstract: The invention relates to an effervescent product for the preparation of an oral rehydration solution for the treatment of diarrhoea. The product comprises oligosaccharides and/or disaccharides, and/or monosaccarides and/or amino acids as energy carriers, and (bi)carbonate and a bicarbonate precursor as alkalizing substances.The product has the form of a tablet or a powder.

Abstract: An intraruminal device for controlled release of a drug formulation in the rumen of an animal, comprises an open-ended tube for containing the drug formulation, a piston adapted to travel longitudinally within the tube and biased so as to deliver the drug formulation through the open end of the tube. Travelling with the piston is an associated weight adapted to retain the device within the rumen during delivery of the drug formulation.

Abstract: A formulation comprising captopril within an enteric or delayed release coated pH stable core combined with additional captopril that is available for immediate release following administration.

Abstract: The present invention relates to a syrup composition characterized in that the composition contains phenobarbital or acetaminophen, a polyhydric alcohol and/or a polymer of a polyhydric alcohol, and a water soluble macromolecule, and the weight ratio of phenobarbital to the polyhydric alcohol and/or the polymer of the polyhydric alcohol is from 1:20 to 1:100, and the weight ratio of phenobarbital to the water soluble macromolecule is from 1:1 to 1:20, which has a reduced bitterness and is easy to take.

Abstract: A biocompatible and/or biodegradable implant for the substantially constant release, by diffusion, of a therapeutic agent in the outside medium at the site of implant which comprises a body consisting of a core defining a solid mass having walls and being formed of a first biocompatible and/or biodegradable polymeric material and having embedded therein a plurality of solid particles of a therapeutic agent which allows for the diffusion of the therapeutic agent from the core in the outside medium; and a coating of a second biocompatible and/or biodegradable polymeric material which prevents the diffusion of the therapeutic agent in the outside medium and the coating covering all but one of the walls. When diodegradable polymers are used, the degradation half-life of the first and second polymeric materials is longer than the diffusion half-life of the therapeutic agent.

Abstract: Psyllium husk comprising particle sizes distributed such that: less than about 15% is larger than about 80 mesh, at least about 45% is within the range of from about 80 mesh to about 200 mesh, and less than about 40% is smaller than about 200 mesh. In addition, psyllium-containing products for oral administration comprising small particle size psyllium husk according to the present invention are described.

Abstract: A non-toxic, non-corrosive, biodegradable disinfectant for use against various pathogenic organisms comprising a homogeneous composition of interactive constituents including anhydrous alcohol, in particular, isopropyl alcohol, propylene glycol, maskant and inert ingredients wherein the propylene glycol reduces the surface glaze formed by the anhydrous alcohol and surface tension formed by water or water-based body fluids enabling the disinfectant to rapidly contact the pathogenic organisms.

Abstract: An antibiotic formulation useful in the treatment of burns and abrasions and adapted for topical application as a clinically water soluble foam, the process for preparing the formulation and a special dispenser system for applying same.

Abstract: An improved method and composition for preventing adhesions during surgery. Tissue surfaces and surgical articles involved in the surgery are coated with a solution of a hydrophilic, polymeric material prior to manipulation of the tissue during surgery. The composition comprises a solution of a polymeric material having a molecular weight of about 500,000 or above having a concentration of from about 0.01 to about 15%, by weight.

Abstract: The invention comprises compositions in solid form of ethylene/vinyl acetate copolymer with an effective amount of bioactive agent, a protein/carbohydrate-lipid source, 0 to 20% of an edible oil and optionally an attractant, dye, preservative, adversive agent and biomarker and the use, thereof, to control pests.

Abstract: Polymeric surfaces of medical devices or components of medical devices are provided that have enhanced biocompatibility properties. The polymeric surface presents an anti-thrombogenic, fibrinolytic or thrombolytic interface with body fluids such as blood during implantation or medical procedures. The biocompatibility enhancing agent is secured to the polymeric substrate by a spacer molecule which is covalently bound to the polymeric substrate which had been subjected to radiofrequency plasma treatment with a water vapor medium.

Abstract: This invention is directed to a delivery system and a method useful for the treatment of benign ovarian secretory disorders in female mammals by administering an LHRH composition. The method comprises administering during the entire follicular phase of the menstrual cycle, beginning at the time of menses, an LHRH composition and sufficient levels of an estrogenic steriod to counteract the possibility of side effects which may develop during prolonged therapy with LHRH. Following the follicular phase, at the beginning of the luteal phase, and for the entire course of the luteal phase, the LHRH/estrogenic steroid combination administered during the follicular phase, in combination with a physiological amount of progestational steroid, is administered.

Abstract: A method of decreasing the melanin content in mammalian skin and hair by administering to a mammal a composition comprising an effective amount of one or more derivatives of 5,6-dihydroxyindole, the derivatives having one or more substituents which are capable of being removed enzymatically, in admixture with a pharmaceutically acceptable carrier, the amount being 0.5% to 20% wt/wt based on the composition.

Abstract: A process and compositons for reducing post-surgical adhesion formation/reformation in mammals following injury to organs situated in mammalian body spaces. Aqueous, thermally reversible gel compositions, preferably at mammalian body fluid pH, comprising a polyoxyalkylene polymer and an ionic polysaccharide are applied to injured areas of the organs situated in body cavities such as, the peritoneal, pelvic, or pleural cavity. The aqueous gels are rendered thermally irreversible upon contact with a counter-ion.

Abstract: The invention provides an orally administered pharmaceutical composition for use in gastrointestinal washes, particularly for diagnostic use, or as a cathartic laxative, of the type containing polyethyleneglycol, anhydrous sodium sulphate, sodium bicarbonate, sodium chloride and potassium chloride, characterized by also containing the following components: saccharin, acesulfame-K and a flavoring chosen from the following: mandarin, fresh fruit flavoring.

Abstract: Balanced pH, thermo-irreversible gels are ideal vehicles for drug injection into the body of a mammal.

Abstract: An antimycotically-active nail varnish, which contains an antimycotically-active substance selected from 4-[3-[p-(.alpha.,.alpha.-dimethyl-benzyl)-phenyl]-2-methyl-propyl]-2,6-dim ethylmorpholine, 4-[-[p-(1,1,-dimethylpropyl)-phenyl]-2-methyl-propyl]-2,6-dimethyl-morphol ine and salts thereof and a water-insoluble film former which a copolymerizate of acrylic acid esters and methacrylic acid esters having a low content of quaternary ammonium groups, is described.

Abstract: Dimethylpolysiloxane is effective in the treatment of ulcers of the gastrointestinal tract.

Abstract: A photo-reactive nail polish coating composition that cures quickly upon exposure to low levels of ultraviolet radiation. Compatible with any commercially available nail polish of any color and removable by standard acetone-based polish removers. Also compatible with every day chores because insoluble in water. The composition is not phototoxic and has very low potential for skin irritation or sensitization. The photo-reactive coating is applied over the wet nail polish and then irradiated with safe dosages of ultraviolet radiation, causing the nail polish to dry in a few minutes.

Abstract: Solid dihydropyridines, e.g. nifedipine and nimodipine preparations having a maximum standard deviation of the active compound content of 3% contain 1 part by weight of nifedipine, 2 to 6 parts by weight of PVP with a mean molecular weight of 15,000 to 50,000, 3.5 to 15 parts by weight of cellulose, 0.25 to 4 parts by weight of starch and 0.5 to 4 parts by weight of cross-linked insoluble PVPP, and, if appropriate, one or more further pharmaceutical auxiliaries and excipients. These preparations show a good release of dihydropyridine with good content uniformity.